Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implications (Q81596683)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Korkolopoulou P

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Thymara I

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Kavantzas N

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Vassilakopoulos TP

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Angelopoulou MK

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Kokoris SI

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Dimitriadou EM

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Siakantaris MP

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Anargyrou K

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Panayiotidis P

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Tsenga A

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Androulaki A

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Doussis-Anagnostopoulou IA

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Patsouris E

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Pangalis GA

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 June 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

894-900

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15800675%20AND%20SRC:MED&resulttype=core&format=json

Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

A morphometric study of bone marrow angiogenesis in hairy cell leukaemia with clinicopathological correlations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

Prognostic evaluation of the microvascular network in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

Angiogenesis in B cell lymphoproliferative diseases. Biological and clinical studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

Intratumoral microvascular density in malignant lymphomas of B-cell origin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

Prognostic significance of microvessel density and vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

Expression of vascular endothelial growth factor in lymphomas and Castleman's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

A morphometric study of neovascularization in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

Re: Doussis-Anagnostopoulouet al. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.J Pathol 2002; 197: 677-683

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403690

7 January 2021